Author： Giordano Thomas
Publisher： Humana Press, Inc
ISSN： 1046-3976
Source： Endocrine Pathology, Vol.14, Iss.2, 2003-06, pp. : 107-116
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Genomewide profiling of gene expression, made possible by the development of DNA microarray technology and more powerful by the sequencing of the human genome, has led to advances in tumor classification and biomarker discovery for the common types of human neoplasia. Application of this approach to the field of endocrine neoplasia is in its infancy, although some progress has been recently reported. In this review, the progress to date is summarized and the promise of DNA microarray analysis in conjunction with tissue array immunohistochemistry to significantly impact endocrine tumor diagnosis and prognosis is discussed.
Related content
Access to resources
Recommend
DNA Methylation and Silencing of Gene Expression
By Newell-Price J. Clark A.J.L. King P.
Trends in Endocrinology and Metabolism, Vol. 11, Iss. 4, 2000-05 ,pp. :